Skip to content

Behaviour of Intravenous Solutions in Obese Patients Under General Anesthesia

Colloid Volume Kinetics in Morbidly Obese Patients Under General Anaesthesia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01652131
Enrollment
12
Registered
2012-07-27
Start date
2012-05-31
Completion date
2012-12-31
Last updated
2012-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Obesity, Morbid

Keywords

general anesthesia, volume kinetics

Brief summary

There is no objective evidence of how long intravenous solutions remain inside venous blood vessels after they have been administered, therefore there is no definite guideline of how to administer them in the preoperative setting. Besides, obese patients represent a particular group of subjects as they theoretically with-hold a constant inflammatory response and that would modify the way solutions behave intravenously, that is how long they remain inside. Having said this, we wish to describe the way colloid solutions behave in this group of patients by taking serial blood samples in 12 obese patients after a colloid infusion, to calculate plasma dilution curves based on hemoglobin dilution and therefore infer the time it remains intravascularly. All this in the hope this information will help, in the near future, to establish a more objective way to use these solutions and avoid possible complications due to over-administration.

Interventions

OTHERTetrastarch (130/0.4)

Sponsors

National Institute of Medical Sciences and Nutrition, Salvador Zubiran
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* clinical diagnosis of obesity (IMC \>35kg/m2) that will be treated with gastrojejunal laparoscopic bypass

Exclusion criteria

* Renal failure KDOQI \>3 * Cardiac failure NYHA III-IV * Sepsis * Allergy to tetrastarch * Allergy to any of the anesthetic medication that is to be used in the protocol previously established * Patients in which vasoactive drugs are used * Patients in which the blood samples are completed.

Design outcomes

Primary

MeasureTime frameDescription
description of colloid volume kinetics in obese patients after the infusion of Tetrastarch (130/0.4)90 minutes after beginning of the infusiondifferent kinetic parameters will be used to asses the behavior of the colloid solution

Countries

Mexico

Contacts

Primary ContactMaria V Hernandez Martinez, M.D.
mvictoria20@me.com52 55 54 87 09 00
Backup ContactGuillermo Dominguez Cherit, M.D.
guidom@prodigy.net.mx52 55 54 87 09 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026